Marker Therapeutics, Inc. (MRKR)

1.45 -0.05 (-3.33%) USD  |  NASDAQ  |  Feb 20, 16:00
1.46 +0.01 (+0.69%) After-Hours: 20:00
More

Marker Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Viridian Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Kiniksa Pharmaceuticals International Plc Upgrade
Neurocrine Biosciences, Inc. Upgrade